ID

18028

Beschreibung

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00322387

Link

https://clinicaltrials.gov/show/NCT00322387

Stichworte

  1. 15.10.16 15.10.16 -
Hochgeladen am

15. Oktober 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lymphoma, Non-Hodgkin NCT00322387

Eligibility Lymphoma, Non-Hodgkin NCT00322387

Criteria
Beschreibung

Criteria

mm in first partial response/complete response, first relapse, or second partial/complete response
Beschreibung

Multiple Myeloma partial response First | Multiple Myeloma complete response First | Multiple Myeloma First Relapse | Multiple Myeloma partial response second | Multiple Myeloma complete response second

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C1521726
UMLS CUI [1,3]
C0205435
UMLS CUI [2,1]
C0026764
UMLS CUI [2,2]
C0677874
UMLS CUI [2,3]
C0205435
UMLS CUI [3,1]
C0026764
UMLS CUI [3,2]
C4054953
UMLS CUI [4,1]
C0026764
UMLS CUI [4,2]
C1521726
UMLS CUI [4,3]
C0205436
UMLS CUI [5,1]
C0026764
UMLS CUI [5,2]
C0677874
UMLS CUI [5,3]
C0205436
nhl in first or second partial or complete remission
Beschreibung

Non-Hodgkin Lymphoma partial response First | Non-Hodgkin Lymphoma partial response second | Non-Hodgkin Lymphoma complete remission First | Non-Hodgkin Lymphoma complete remission second

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C1521726
UMLS CUI [1,3]
C0205435
UMLS CUI [2,1]
C0024305
UMLS CUI [2,2]
C1521726
UMLS CUI [2,3]
C0205436
UMLS CUI [3,1]
C0024305
UMLS CUI [3,2]
C0677874
UMLS CUI [3,3]
C0205435
UMLS CUI [4,1]
C0024305
UMLS CUI [4,2]
C0677874
UMLS CUI [4,3]
C0205436
nhl patients who do not have bone marrow involvement and < 10% for follicular involvement
Beschreibung

Lymphoma, Non-Hodgkin | Bone Marrow Involvement | Involvement Follicular Percentage

Datentyp

boolean

Alias
UMLS CUI [1]
C0024305
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C1314939
UMLS CUI [3,1]
C1314939
UMLS CUI [3,2]
C0439682
UMLS CUI [3,3]
C0439165
mm patients who have stable disease with < 40% bone marrow involvement
Beschreibung

Multiple Myeloma Stable | Bone Marrow Percentage Involvement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C1314939
no more than three prior regimens of chemotherapy (thalidomide and decadron are not considered chemotherapy)
Beschreibung

Prior Chemotherapy Quantity | Thalidomide | Decadron

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0039736
UMLS CUI [3]
C0740057
eastern cooperative oncology group (ecog) performance status of 0 or 1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
white blood cell count (wbc) >3.0 x 10^9/l
Beschreibung

White Blood Cell Count procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0023508
absolute neutrophil count >1.5 x 10^9/l
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count >100 x 10^9/l
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
exclusion criteria (abbreviated list):
Beschreibung

Exclusion Criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
brain metastases or carcinomatous meningitis
Beschreibung

Metastatic malignant neoplasm to brain | Meningeal Carcinomatosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0220654
hypercalcaemia [>1 mg/dl above the upper limit of normal (uln)]
Beschreibung

Hypercalcemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0020437
cardiovascular disease that includes proven or predisposition to ventricular arrhythmias
Beschreibung

Cardiovascular Diseases | Ventricular arrhythmia | Ventricular arrhythmia Predisposition

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0085612
UMLS CUI [3,1]
C0085612
UMLS CUI [3,2]
C0220898
acute infection
Beschreibung

Communicable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450

Ähnliche Modelle

Eligibility Lymphoma, Non-Hodgkin NCT00322387

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Multiple Myeloma partial response First | Multiple Myeloma complete response First | Multiple Myeloma First Relapse | Multiple Myeloma partial response second | Multiple Myeloma complete response second
Item
mm in first partial response/complete response, first relapse, or second partial/complete response
boolean
C0026764 (UMLS CUI [1,1])
C1521726 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0026764 (UMLS CUI [2,1])
C0677874 (UMLS CUI [2,2])
C0205435 (UMLS CUI [2,3])
C0026764 (UMLS CUI [3,1])
C4054953 (UMLS CUI [3,2])
C0026764 (UMLS CUI [4,1])
C1521726 (UMLS CUI [4,2])
C0205436 (UMLS CUI [4,3])
C0026764 (UMLS CUI [5,1])
C0677874 (UMLS CUI [5,2])
C0205436 (UMLS CUI [5,3])
Non-Hodgkin Lymphoma partial response First | Non-Hodgkin Lymphoma partial response second | Non-Hodgkin Lymphoma complete remission First | Non-Hodgkin Lymphoma complete remission second
Item
nhl in first or second partial or complete remission
boolean
C0024305 (UMLS CUI [1,1])
C1521726 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0024305 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
C0205436 (UMLS CUI [2,3])
C0024305 (UMLS CUI [3,1])
C0677874 (UMLS CUI [3,2])
C0205435 (UMLS CUI [3,3])
C0024305 (UMLS CUI [4,1])
C0677874 (UMLS CUI [4,2])
C0205436 (UMLS CUI [4,3])
Lymphoma, Non-Hodgkin | Bone Marrow Involvement | Involvement Follicular Percentage
Item
nhl patients who do not have bone marrow involvement and < 10% for follicular involvement
boolean
C0024305 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C1314939 (UMLS CUI [3,1])
C0439682 (UMLS CUI [3,2])
C0439165 (UMLS CUI [3,3])
Multiple Myeloma Stable | Bone Marrow Percentage Involvement
Item
mm patients who have stable disease with < 40% bone marrow involvement
boolean
C0026764 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C1314939 (UMLS CUI [2,3])
Prior Chemotherapy Quantity | Thalidomide | Decadron
Item
no more than three prior regimens of chemotherapy (thalidomide and decadron are not considered chemotherapy)
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0039736 (UMLS CUI [2])
C0740057 (UMLS CUI [3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
White Blood Cell Count procedure
Item
white blood cell count (wbc) >3.0 x 10^9/l
boolean
C0023508 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count >1.5 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count >100 x 10^9/l
boolean
C0032181 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria (abbreviated list):
boolean
C0680251 (UMLS CUI [1])
Metastatic malignant neoplasm to brain | Meningeal Carcinomatosis
Item
brain metastases or carcinomatous meningitis
boolean
C0220650 (UMLS CUI [1])
C0220654 (UMLS CUI [2])
Hypercalcemia
Item
hypercalcaemia [>1 mg/dl above the upper limit of normal (uln)]
boolean
C0020437 (UMLS CUI [1])
Cardiovascular Diseases | Ventricular arrhythmia | Ventricular arrhythmia Predisposition
Item
cardiovascular disease that includes proven or predisposition to ventricular arrhythmias
boolean
C0007222 (UMLS CUI [1])
C0085612 (UMLS CUI [2])
C0085612 (UMLS CUI [3,1])
C0220898 (UMLS CUI [3,2])
Communicable Disease
Item
acute infection
boolean
C0009450 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video